Fiamma Buttitta - Concepedia

Author

Fiamma Buttitta

University of Chieti-Pescara

Also Known As

Buttitta F, Buttitta F., F BUTTITTA, F Buttitta, F. Buttitta, F., Buttitta, FIAMMA BUTTITTA, Fiamma Buttitta

160

Publications

9.4K

Citations

H-Index

Concepts

All Affiliations

University of Chieti-Pescara University of Pisa European Institute of Oncology University of Milan Fondazione IRCCS Istituto Nazionale dei Tumori

About

Fiamma Buttitta is an author at University of Chieti-Pescara specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	42	4.6K
2	Health Sciences	3	3	117
3	Biostatistics	2	2	161
4	Engineering	1	1	366
5	Public Health	1	1	190

Fiamma Buttitta

Publications

Citations

H-Index

Page 1

	Year	Citations
<i>EGFR</i> Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment Antonio Marchetti, Carla Martella, Lara Felicioni, Journal of Clinical Oncology	2005	792
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring <i>BRAF</i> Mutations Antonio Marchetti, Lara Felicioni, Sara Malatesta, Journal of Clinical Oncology Cancer RiskCancer EpidemiologyMedicineBraf MutationsResults Braf Mutations	2011	559
Increased <i>MET</i> Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients Federico Cappuzzo, Antonio Marchetti, Margaret C. Skokan, Journal of Clinical Oncology	2009	550
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Luping Lin, Amit J. Sabnis, Elton Chan, Nature Genetics MedicineMek-targeted Cancer TherapiesHippo Effector YapCancer BiologyCell Biology	2015	548
microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer Riccardo Cazzoli, Fiamma Buttitta, Marta Di Nicola, Journal of Thoracic Oncology Tumor BiologyExtracellular VesiclesExosomesMedicineBiomarker Target	2013	444
<i>IDH1</i>mutations at residue p.R132 (IDH1<sup>R132</sup>) occur frequently in high-grade gliomas but not in other solid tumors Fonnet E. Bleeker, Simona Lamba, Sieger Leenstra, Human Mutation EngineeringGeneticsPathologyMolecular BiologyOther Solid Tumors	2009	366
AKT1E17K in human solid tumours F E Bleeker, L Felicioni, Fiamma Buttitta, Oncogene Human Solid TumoursMedicinePathologyOncologyMalignant Disease	2008	206
Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the <i>PIK3CA</i> Gene in Breast Carcinomas Mattia Barbareschi, Fiamma Buttitta, Lara Felicioni, Clinical Cancer Research	2007	193
Association between cigarette smoking and FHIT gene alterations in lung cancer. Gabriella Sozzi, Laura Sard, Laura De Gregorio, PubMed Cigarette SmokingTobacco ControlTobacco DamageTobacco UseFhit Gene	1997	190
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients Antonio Marchetti, John F. Palma, Lara Felicioni, Journal of Thoracic Oncology	2015	175

Page 1